DiaSpect Medical, EKF Diagnostics, Selah Genomics deal

Diagnostic company EKF acquired Selah Genomics and DiaSpect Medical in cash and stock deals that value Selah at up to

Read the full 206 word article

How to gain access

Continue reading with a
two-week free trial.